Immuneering Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
23.67
|
|
Average Rating
|
4.57
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.61
|
0.00
|
0.61
|
100.00%
|
|
2022-12-31
|
-0.58
|
0.00
|
0.58
|
100.00%
|
|
2022-09-30
|
-0.49
|
-0.49
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.52
|
-0.44
|
0.08
|
15.38%
|
|
2022-03-31
|
-0.45
|
-0.49
|
-0.04
|
-8.89%
|
|
2021-12-31
|
-0.39
|
-0.42
|
-0.03
|
-7.69%
|
|
2021-09-30
|
-0.57
|
-0.47
|
0.10
|
17.54%
|
|
2021-06-30
|
-1.44
|
-1.61
|
-0.17
|
-11.81%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.42
|
|
2021-12-31
|
-3.76
|
|
2020-12-31
|
-1.26
|
|
2019-12-31
|
-0.65
|